| RS2505719610 |
ALPK3
|
Health Risk |
Pathogenic |
— |
| RS2505719661 |
ALPK3
|
Health Risk |
Pathogenic |
— |
| RS2505719933 |
ALPK3
|
Health Risk |
Pathogenic/Likely pathogenic |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS2505720068 |
ALPK3
|
Health Risk |
Pathogenic |
— |
| RS2505720215 |
ALPK3
|
Health Risk |
Pathogenic |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS2505720338 |
ALPK3
|
Health Risk |
Pathogenic |
— |
| RS2505720575 |
ALPK3
|
Health Risk |
Pathogenic/Likely pathogenic |
Cardiomyopathy, familial hypertrophic 27 |
| RS2505720732 |
ALPK3
|
Health Risk |
Pathogenic |
— |
| RS2505720978 |
ALPK3
|
Health Risk |
Likely pathogenic |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS2505720989 |
ALPK3
|
Health Risk |
Pathogenic |
— |
| RS2505721119 |
ALPK3
|
Health Risk |
Pathogenic/Likely pathogenic |
— |
| RS2505721388 |
ALPK3
|
Health Risk |
Pathogenic |
— |
| RS2505721674 |
ALPK3
|
Health Risk |
Pathogenic |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS2505721718 |
ALPK3
|
Health Risk |
Likely pathogenic |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS2505722050 |
ALPK3
|
Health Risk |
Pathogenic |
— |
| RS2505722343 |
ALPK3
|
Health Risk |
Pathogenic |
— |
| RS2505722420 |
ALPK3
|
Health Risk |
Pathogenic |
— |
| RS2505722433 |
ALPK3
|
Health Risk |
Likely pathogenic |
Cardiomyopathy, familial hypertrophic 27 |
| RS2505722472 |
ALPK3
|
Health Risk |
Pathogenic |
— |
| RS2505722565 |
ALPK3
|
Health Risk |
Pathogenic |
— |
| RS2505722576 |
ALPK3
|
Health Risk |
Likely pathogenic |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS2505722754 |
ALPK3
|
Health Risk |
Pathogenic |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS2505722871 |
ALPK3
|
Health Risk |
Pathogenic/Likely pathogenic |
Cardiovascular phenotype, Cardiomyopathy |
| RS2505722938 |
ALPK3
|
Health Risk |
Likely pathogenic |
— |
| RS2505723818 |
ALPK3
|
Health Risk |
Pathogenic/Likely pathogenic |
Cardiovascular phenotype, Cardiomyopathy |
| RS2505723820 |
ALPK3
|
Health Risk |
Likely pathogenic |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS2505723959 |
ALPK3
|
Health Risk |
Pathogenic |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS2505724060 |
ALPK3
|
Health Risk |
Likely pathogenic |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS2505724394 |
SPG11
|
Health Risk |
Likely pathogenic |
Hereditary spastic paraplegia 11, Hereditary spastic paraplegia 11 |
| RS2505724467 |
ROGDI
|
Health Risk |
Pathogenic |
Amelocerebrohypohidrotic syndrome, Amelocerebrohypohidrotic syndrome |
| RS2505724567 |
SPG11
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 11, Hereditary spastic paraplegia 11 |
| RS2505724668 |
ALPK3
|
Health Risk |
Likely pathogenic |
— |
| RS2505724987 |
ALPK3
|
Health Risk |
Likely pathogenic |
— |
| RS2505725884 |
SPG11
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary spastic paraplegia 11, Amyotrophic lateral sclerosis type 5 |
| RS2505726481 |
SPG11
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 11, Hereditary spastic paraplegia 11 |
| RS2505727260 |
ALPK3
|
Health Risk |
Likely pathogenic |
Cardiomyopathy, familial hypertrophic 27 |
| RS2505727425 |
ALPK3
|
Health Risk |
Pathogenic |
— |
| RS2505727517 |
ALPK3
|
Health Risk |
Likely pathogenic |
ALPK3-related disorder, ALPK3-related disorder |
| RS2505727615 |
ROGDI
|
Health Risk |
Pathogenic |
Amelocerebrohypohidrotic syndrome, Amelocerebrohypohidrotic syndrome |
| RS2505727626 |
ALPK3
|
Health Risk |
Pathogenic |
— |
| RS2505727696 |
SPG11
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Hereditary spastic paraplegia 11 |
| RS2505728562 |
ALPK3
|
Health Risk |
Likely pathogenic |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS2505728928 |
SPG11
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 11, Hereditary spastic paraplegia 11 |
| RS2505729570 |
ALPK3
|
Health Risk |
Pathogenic |
— |
| RS2505729802 |
ALPK3
|
Health Risk |
Likely pathogenic |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS2505729878 |
ALPK3
|
Health Risk |
Likely pathogenic |
Cardiomyopathy, familial hypertrophic 27 |
| RS2505736836 |
ROGDI
|
Health Risk |
Pathogenic |
Amelocerebrohypohidrotic syndrome, Amelocerebrohypohidrotic syndrome |
| RS2505745149 |
LRRK1
|
Health Risk |
Pathogenic |
— |
| RS2505754783 |
FBN1
|
Health Risk |
Pathogenic |
Marfan syndrome, Familial thoracic aortic aneurysm and aortic dissection |
| RS2505755130 |
FBN1
|
Health Risk |
Likely pathogenic |
Marfan syndrome, Marfan syndrome |
| RS2505755152 |
FBN1
|
Health Risk |
Pathogenic |
Familial thoracic aortic aneurysm and aortic dissection, Familial thoracic aortic aneurysm and aortic dissection |
| RS2505758285 |
SPG11
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 11, Hereditary spastic paraplegia 11 |
| RS2505759097 |
SPG11
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 11, Hereditary spastic paraplegia 11 |
| RS2505759290 |
SPG11
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 11, Hereditary spastic paraplegia 11 |
| RS2505760925 |
FBN1
|
Health Risk |
Pathogenic |
Familial thoracic aortic aneurysm and aortic dissection, Familial thoracic aortic aneurysm and aortic dissection |
| RS2505760991 |
FBN1
|
Health Risk |
Pathogenic/Likely pathogenic |
Familial thoracic aortic aneurysm and aortic dissection, Marfan syndrome |
| RS2505761195 |
FBN1
|
Health Risk |
Likely pathogenic |
Marfan syndrome, Marfan syndrome |
| RS2505768771 |
SPG11
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 11, Hereditary spastic paraplegia 11 |
| RS2505769438 |
NR2F2
|
Health Risk |
Likely pathogenic |
NR2F2 associated disorders, NR2F2 associated disorders |
| RS2505770216 |
NR2F2
|
Health Risk |
Pathogenic |
— |
| RS2505774176 |
NR2F2
|
Health Risk |
Likely pathogenic |
Congenital heart defects, multiple types |
| RS2505774216 |
NR2F2
|
Health Risk |
Pathogenic |
Congenital heart defects, multiple types |
| RS2505774507 |
NR2F2
|
Health Risk |
Likely pathogenic |
Congenital heart defects, multiple types |
| RS2505774793 |
NR2F2
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2505775271 |
NR2F2
|
Health Risk |
Likely pathogenic |
— |
| RS2505775333 |
SPG11
|
Health Risk |
Likely pathogenic |
Hereditary spastic paraplegia 11, Hereditary spastic paraplegia 11 |
| RS2505775559 |
FBN1
|
Health Risk |
Pathogenic |
Familial thoracic aortic aneurysm and aortic dissection, Marfan syndrome |
| RS2505775597 |
FBN1
|
Health Risk |
Pathogenic |
Familial thoracic aortic aneurysm and aortic dissection, Marfan syndrome |
| RS2505775608 |
FBN1
|
Health Risk |
Likely pathogenic |
Weill-Marchesani syndrome 2, dominant |
| RS2505775624 |
FBN1
|
Health Risk |
Pathogenic |
Familial thoracic aortic aneurysm and aortic dissection, Familial thoracic aortic aneurysm and aortic dissection |
| RS2505775671 |
SPG11
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 11, Hereditary spastic paraplegia 11 |
| RS2505775850 |
FBN1
|
Health Risk |
Pathogenic |
Marfan syndrome, Familial thoracic aortic aneurysm and aortic dissection |
| RS2505775858 |
FBN1
|
Health Risk |
Pathogenic |
Familial thoracic aortic aneurysm and aortic dissection, Marfan syndrome |
| RS2505779155 |
FBN1
|
Health Risk |
Pathogenic |
Marfan syndrome, Familial thoracic aortic aneurysm and aortic dissection |
| RS2505779180 |
FBN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial thoracic aortic aneurysm and aortic dissection, Marfan syndrome |
| RS2505779226 |
FBN1
|
Health Risk |
Pathogenic |
Marfan syndrome, Familial thoracic aortic aneurysm and aortic dissection |
| RS2505779274 |
FBN1
|
Health Risk |
Pathogenic |
Familial thoracic aortic aneurysm and aortic dissection, Marfan syndrome |
| RS2505779321 |
FBN1
|
Health Risk |
Pathogenic |
Marfan syndrome, Marfan syndrome |
| RS2505779337 |
FBN1
|
Health Risk |
Pathogenic |
Marfan syndrome, Familial thoracic aortic aneurysm and aortic dissection |
| RS2505779992 |
NR2F2
|
Health Risk |
Likely pathogenic |
Congenital heart defects, multiple types |
| RS2505780251 |
NR2F2
|
Health Risk |
Likely pathogenic |
NR2F2 associated disorders, NR2F2 associated disorders |
| RS2505780323 |
NR2F2
|
Health Risk |
Likely pathogenic |
46, xx sex reversal 5 |
| RS2505794258 |
ABCD4
|
Health Risk |
Likely pathogenic |
Methylmalonic acidemia with homocystinuria, type cblJ |
| RS2505795420 |
SPG11
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 11, Hereditary spastic paraplegia 11 |
| RS2505808015 |
NIN
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS2505809803 |
MPI
|
Health Risk |
Likely pathogenic |
MPI-congenital disorder of glycosylation, MPI-congenital disorder of glycosylation |
| RS2505811178 |
MPI
|
Health Risk |
Pathogenic |
MPI-congenital disorder of glycosylation, MPI-congenital disorder of glycosylation |
| RS2505811185 |
MPI
|
Health Risk |
Pathogenic |
MPI-congenital disorder of glycosylation, MPI-congenital disorder of glycosylation |
| RS2505811190 |
MPI
|
Health Risk |
Pathogenic |
MPI-congenital disorder of glycosylation, MPI-congenital disorder of glycosylation |
| RS2505811218 |
MPI
|
Health Risk |
Likely pathogenic |
MPI-congenital disorder of glycosylation, MPI-congenital disorder of glycosylation |
| RS2505811246 |
MPI
|
Health Risk |
Pathogenic |
MPI-congenital disorder of glycosylation, MPI-congenital disorder of glycosylation |
| RS2505811515 |
MPI
|
Health Risk |
Pathogenic |
MPI-congenital disorder of glycosylation, MPI-congenital disorder of glycosylation |
| RS2505811546 |
MPI
|
Health Risk |
Likely pathogenic |
MPI-congenital disorder of glycosylation, MPI-congenital disorder of glycosylation |
| RS2505811587 |
MPI
|
Health Risk |
Likely pathogenic |
MPI-congenital disorder of glycosylation, MPI-congenital disorder of glycosylation |
| RS2505811612 |
MPI
|
Health Risk |
Likely pathogenic |
MPI-congenital disorder of glycosylation, MPI-congenital disorder of glycosylation |
| RS2505813008 |
CLCN7
|
Health Risk |
Likely pathogenic |
— |
| RS2505813091 |
CLCN7
|
Health Risk |
Pathogenic |
— |
| RS2505813236 |
CLCN7
|
Health Risk |
Likely pathogenic |
— |
| RS2505813641 |
MPI
|
Health Risk |
Likely pathogenic |
MPI-congenital disorder of glycosylation, MPI-congenital disorder of glycosylation |
| RS2505813657 |
MPI
|
Health Risk |
Pathogenic |
MPI-congenital disorder of glycosylation, MPI-congenital disorder of glycosylation |